Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Evidence for molecular subtyping in pancreatic ductal adenocarcinoma: a systematic review.

HPB : the official journal of the International Hepato Pancreato Biliary Association - 1 May 2024

Robertson Francis P, Cameron Andrew, Spiers Harry V M, Joseph Nejo, Taylor Ellie, Ratnayake Bathiya, Jamieson Nigel B, Pandanaboyana Sanjay

Abstract excerpt

BACKGROUND: Pancreatic Ductal Adenocarcinoma (PDAC) patients exhibit varied responses to multimodal therapy. RNA gene sequencing has unravelled distinct tumour biology subtypes, forming the focus of this review exploring its impact on survival outcomes. METHODS: A systematic search across PubMed, Medline, Embase, and CINAHL databases targeted studies assessing long-term overall and disease-free survival in PDAC...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Carcinoma, Pancreatic Ductal

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Disease-Free Survival

Share to Immunohistochemistry

Share to Pancreatic Neoplasms

Share to Phenotype

Share to Predictive Value of Tests

Share to Sequence Analysis, RNA

Source

Identifiers

PMID: 38401998
DOI: 10.1016/j.hpb.2024.02.001

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Evidence for molecular subtyping in pancreatic ductal adenocarcinoma: a systematic review.PMID 38401998Read ↗

Clinical Impact of Molecular Subtyping of Pancreatic CancerSemantic proximity Read ↗

Clinical utility of molecular subtyping of pancreatic cancerSemantic proximity Read ↗

Transcriptomic, Genomic, and Clinical Characterization of Morphological Classes in Localized and Metastatic Pancreatic CancerSemantic proximity Read ↗

Molecular classification as prognostic factor and guide for treatment decision of pancreatic cancer.Semantic proximity Read ↗

Elucidation of Tumor-Stromal Heterogeneity and the Ligand-Receptor Interactome by Single-Cell Transcriptomics in Real-world Pancreatic Cancer BiopsiesSemantic proximity Read ↗

Therapeutic trends in pancreatic ductal adenocarcinoma (PDAC)Semantic proximity Read ↗

Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma.Semantic proximity Read ↗

Therapeutic Implications of Molecular Subtyping for Pancreatic Cancer.Semantic proximity Read ↗

Morphological classification of pancreatic ductal adenocarcinoma that predicts molecular subtypes and correlates with clinical outcomeSemantic proximity Read ↗

Minimally invasive determination of PDAC subtype and therapy-induced subtype switch by means of circulating cell-free RNASemantic proximity Read ↗

Molecular classification and prognosis study of pancreatic ductal adenocarcinoma through multi-omics integrated clustering analysis.Semantic proximity Read ↗

The Limits of Molecular Signatures for Pancreatic Ductal Adenocarcinoma SubtypingSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.